Document is current
Any future updates will be listed below
-
Authors
Schiaffino, Simone https://orcid.org/0000-0003-4243-888X
Bernardi, Daniela
Healy, Nuala
Marino, Maria Adele
Romeo, Valeria
Sechopoulos, Ioannis
Mann, Ritse M.
Pinker, Katja
- License Information
-
More Information
Article History
Received: 18 April 2025
Revised: 27 June 2025
Accepted: 12 July 2025
First Online: 26 August 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Katja Pinker.
: The authors of this manuscript declare relationships with the following companies: Simone Schiaffino Consulting fees from Tempus; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from GE HealthCare; and support for attending meetings and/or travel from Bracco. Member of the European Society of Radiology Research Committee; member of the editorial board for European Journal of Radiology and European Radiology Experimental. Ritse Mann Grants or contracts from the Dutch Cancer Society, Europees Fonds voor Regionale Ontwikkeling Programma Oost-Nederland, Horizon Europe, European Research Council, Dutch Research Council, Health Holland, Siemens Healthineers, Bayer, ScreenPoint Medical, Beckton Dickinson, PA Imaging, Lunit, and Koning Health; royalties or licenses from Elsevier; consulting fees from Siemens Healthineers, Bayer, ScreenPoint Medical, Beckton Dickinson, PA Imaging, Lunit, Koning Health, and Guerbet; participation on a data and safety monitoring board or advisory board for the SMALL trial; member of the European Society of Breast Imaging executive board; member of the European Society of Radiology Research Committee; member of the editorial board for European Journal of Radiology; member of the Dutch Breast Cancer Research Group; and associate editor for Radiology. Katja Pinker Grants or contracts from the Research and Innovation Framework Programme, FET Open, Anniversary Fund of the Oesterreichische Nationalbank, Vienna Science and Technology Fund, Memorial Sloan Kettering Cancer Center, and Breast Cancer Research Foundation; unpaid consultant for Genentech; consulting fees from Merantix, AURA Health Technologies, and Guerbet; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from the European Society of Breast Imaging, Bayer, Siemens Healthineers, International Diagnostic Course Davos, Olea Medical, and Roche; support for attending meetings and/or travel from the European Society of Breast Imaging; participation on a data and safety monitoring board or advisory board for Bayer and Guerbet; and institution (Memorial Sloan Kettering Cancer Center) has institutional financial interests relative to Grail. The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary.
: Written informed consent was not required.
: Institutional Review Board approval was not required.
: Not applicable.
:
